HHLR Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

HHLR Advisors’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,100,000	Closed	-$21.9M	–	73
2022 Q3	$21.9M	Hold	1,100,000	–	–	0.58%	28
2022 Q2	$7.58M	Hold	1,100,000	–	–	0.16%	38
2022 Q1	$10.2M	Hold	1,100,000	–	–	0.21%	33
2021 Q4	$15.6M	Hold	1,100,000	–	–	0.24%	40
2021 Q3	$25.5M	Hold	1,100,000	–	–	0.33%	39
2021 Q2	$27.4M	Hold	1,100,000	–	–	0.28%	46
2021 Q1	$30.8M	Hold	1,100,000	–	–	0.3%	38
2020 Q4	$38.4M	Buy	1,100,000 +600,000	+120%	+$26.1M	0.31%	43
2020 Q3	$24.9M	Hold	500,000	–	–	0.19%	43
2020 Q2	$23.2M	Buy	+500,000	New	+$21.7M	0.21%	43

HHLR Advisors's FMTX Position: Q4 2022 in Review

HHLR Advisors sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 1,100,000 shares — an estimated $21.9M sold.

HHLR Advisors first reported a position in FMTX in Q2 2020 and held it in 10 quarters. The position peaked at $38.4M in Q4 2020. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

HHLR Advisors reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
HHLR Advisors sold 1,100,000 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $21.9M.
HHLR Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
HHLR Advisors's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $38.4M in Q4 2020.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on HHLR Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.